| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.09 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.24 | 0.09 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |